Federal grants to Recombinetics Inc
Recombinetics Inc in Saint Paul, Minnesota received $2.4 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Trans-NIH Research Support, with $1.7 million. In fiscal 2025 more was taken back from its awards than added, a net -$44,223.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.4 million
- Awards4
- Awarded in FY 2025-$44,223
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $781,473 |
| FY 2022 | 1 | $943,024 |
| FY 2023 | 1 | $342,154 |
| FY 2024 | 2 | $384,999 |
| FY 2025 | 0 | -$44,223 |
Programs that fund Recombinetics Inc
| Program | Awards | Amount |
|---|---|---|
| Trans-NIH Research Support | 1 | $1.7 million |
| Cancer Treatment Research | 1 | $297,931 |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $228,863 |
| Research Infrastructure Programs | 1 | $156,136 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $2.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of swine reporter models for testing somatic cell genome editing tools | Trans-NIH Research Support | August 19, 2021 | $1.7 million |
| An inducible swine hepatocellular carcinoma platform for enhanced therapeutic development - project summary hepatocellular carcinoma (HCC) is a global health burden ranking as the fourth most common and second deadliest cancer in the world. Effective therapeutic strategies for hcc, especially at adv | Cancer Treatment Research | August 23, 2023 | $297,931 |
| Gene therapy for mps IV a in a novel porcine model of the disease - project summary this project centers on addressing the challenges posed by mps IV a, a rare lysosomal storage disease caused by a deficiency in the galns enzyme due to mutations in the galns gene. Existing treatments, such as enzyme | Arthritis, Musculoskeletal and Skin Diseases Research | September 18, 2024 | $228,863 |
| Gene therapy for mps IV a in a novel porcine model of the disease - project summary this project centers on addressing the challenges posed by mps IV a, a rare lysosomal storage disease caused by a deficiency in the galns enzyme due to mutations in the galns gene. Existing treatments, such as enzyme | Research Infrastructure Programs | September 18, 2024 | $156,136 |
Questions people ask
How much federal grant money does Recombinetics Inc get?
$2.4 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Recombinetics Inc the most?
The Department of Health and Human Services, with $2.4 million in 4 awards.
What is Recombinetics Inc's largest federal grant?
$1.7 million under Trans-NIH Research Support, with its first action in the period on August 19, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Recombinetics Inc?
Its largest are Trans-NIH Research Support, Cancer Treatment Research and Arthritis, Musculoskeletal and Skin Diseases Research.
Other grant recipients in Saint Paul
- Minnesota Department of Human Services
- Minnesota Department of Transportation
- Department of Commerce Minnesota
- Minnesota Department of Health
- The State of Minnesota of Employment & Economic Development
- Minnesota Department of Public Safety
- Judiciary Courts of State of Minnesota
- Minnesota Public Facilities Authority
Largest federal grant recipients in Minnesota · Federal grants in Minnesota